BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) transmission and infections are a continuing problem in hospitals. Although some have recommended universal surveillance for MRSA at hospital admission to identify and to isolate MRSA-colonized patients, there is a need for formal economic studies to determine the cost-effectiveness of such a strategy. METHODS: We developed a stochastic computer simulation model to determine the potential economic impact of performing MRSA surveillance (ie, single culture of an anterior nares specimen) for all hospital admissions at different MRSA prevalences and basic reproductive rate thresholds from the societal and third party-payor perspectives. Patients with positive surveillance culture results were placed under isolation precautions to prevent transmission by way of respiratory droplets. MRSA-colonized patients who were not isolated could transmit MRSA to other hospital patients. RESULTS: The performance of universal MRSA surveillance was cost-effective (defined as an incremental cost-effectiveness ratio of less than $50,000 per quality-adjusted life-year) when the basic reproductive rate was 0.25 or greater and the prevalence was 1% or greater. In fact, surveillance was the dominant strategy when the basic reproductive rate was 1.5 or greater and the prevalence was 15% or greater, the basic reproductive rate was 2.0 or greater and the prevalence was 10% or greater, and the basic reproductive rate was 2.5 or greater and the prevalence was 5% or greater. CONCLUSIONS: Universal MRSA surveillance of adults at hospital admission appears to be cost-effective at a wide range of prevalence and basic reproductive rate values. Individual hospitals and healthcare systems could compare their prevailing conditions (eg, the prevalence of MRSA colonization and MRSA transmission dynamics) with the benchmarks in our model to help determine their optimal local strategies.
BACKGROUND:Methicillin-resistant Staphylococcus aureus (MRSA) transmission and infections are a continuing problem in hospitals. Although some have recommended universal surveillance for MRSA at hospital admission to identify and to isolate MRSA-colonized patients, there is a need for formal economic studies to determine the cost-effectiveness of such a strategy. METHODS: We developed a stochastic computer simulation model to determine the potential economic impact of performing MRSA surveillance (ie, single culture of an anterior nares specimen) for all hospital admissions at different MRSA prevalences and basic reproductive rate thresholds from the societal and third party-payor perspectives. Patients with positive surveillance culture results were placed under isolation precautions to prevent transmission by way of respiratory droplets. MRSA-colonized patients who were not isolated could transmit MRSA to other hospital patients. RESULTS: The performance of universal MRSA surveillance was cost-effective (defined as an incremental cost-effectiveness ratio of less than $50,000 per quality-adjusted life-year) when the basic reproductive rate was 0.25 or greater and the prevalence was 1% or greater. In fact, surveillance was the dominant strategy when the basic reproductive rate was 1.5 or greater and the prevalence was 15% or greater, the basic reproductive rate was 2.0 or greater and the prevalence was 10% or greater, and the basic reproductive rate was 2.5 or greater and the prevalence was 5% or greater. CONCLUSIONS: Universal MRSA surveillance of adults at hospital admission appears to be cost-effective at a wide range of prevalence and basic reproductive rate values. Individual hospitals and healthcare systems could compare their prevailing conditions (eg, the prevalence of MRSA colonization and MRSA transmission dynamics) with the benchmarks in our model to help determine their optimal local strategies.
Authors: Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr Journal: Infect Control Hosp Epidemiol Date: 2003-05 Impact factor: 3.254
Authors: M H Wernitz; S Swidsinski; K Weist; D Sohr; W Witte; K-P Franke; D Roloff; H Rüden; S K Veit Journal: Clin Microbiol Infect Date: 2005-06 Impact factor: 8.067
Authors: N Troillet; Y Carmeli; M H Samore; J Dakos; K Eichelberger; P C DeGirolami; A W Karchmer Journal: Infect Control Hosp Epidemiol Date: 1998-03 Impact factor: 3.254
Authors: Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: Bruce Y Lee; Tina-Marie Assi; Jayant Rajgopal; Bryan A Norman; Sheng-I Chen; Shawn T Brown; Rachel B Slayton; Souleymane Kone; Hailu Kenea; Joel S Welling; Diana L Connor; Angela R Wateska; Anirban Jana; Ann E Wiringa; Willem G Van Panhuis; Donald S Burke Journal: Am J Public Health Date: 2011-11-28 Impact factor: 9.308
Authors: James A McKinnell; Sarah M Bartsch; Bruce Y Lee; Susan S Huang; Loren G Miller Journal: Infect Control Hosp Epidemiol Date: 2015-07 Impact factor: 3.254
Authors: L Lapointe-Shaw; T Voruganti; P Kohler; H-H Thein; B Sander; A McGeer Journal: Eur J Clin Microbiol Infect Dis Date: 2017-01-11 Impact factor: 3.267
Authors: James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2013-08-19 Impact factor: 3.254
Authors: James A McKinnell; Sarah M Bartsch; Bruce Y Lee; Susan S Huang; Loren G Miller Journal: Infect Control Hosp Epidemiol Date: 2015-01 Impact factor: 3.254
Authors: Melanie L Yarbrough; David K Warren; Karen Allen; Dennis Burkholder; Robert Daum; Curtis Donskey; Dennis Knaack; Anthony LaMarca; Larissa May; Loren G Miller; David M Parenti; Lance Peterson; Thean Yen Tan; Raymond Widen; Diana R Hernandez; Donna M Wolk; C A Burnham Journal: J Clin Microbiol Date: 2017-12-26 Impact factor: 5.948
Authors: Bruce Y Lee; Sarah M Bartsch; Kim F Wong; S Levent Yilmaz; Taliser R Avery; Ashima Singh; Yeohan Song; Diane S Kim; Shawn T Brown; Margaret A Potter; Richard Platt; Susan S Huang Journal: Health Aff (Millwood) Date: 2012-10 Impact factor: 6.301
Authors: David E Payne; Nicholas R Martin; Katherine R Parzych; Alex H Rickard; Adam Underwood; Blaise R Boles Journal: Infect Immun Date: 2012-12-03 Impact factor: 3.441